StemCell Institute Inc. (TYO:7096)
637.00
-3.00 (-0.47%)
Nov 18, 2026, 9:49 AM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 6.41 billion as of November 17, 2026. It is the 31,405th most valuable company in the world and the 2,824th biggest in Japan. Its market cap has decreased by 19.87% in one year.
Market Cap
6.41B
Enterprise Value
4.88B
Revenue
2.81B
Global Rank
Country Rank
#2,824 Japan
PE Ratio
41.50
ChartMarket Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 6.41B, a decrease of -69.68%. That is a compound annual growth rate of -19.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 6.41B | -19.67% |
| Dec 30, 2025 | 7.99B | -39.54% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 7.58B |
| Carna Biosciences | 7.39B |
| Kidswell Bio | 7.19B |
| ADR Biomedical Holdings | 6.70B |
| Nano Holdings | 6.28B |
| TMS Co., Ltd. | 6.26B |
| CellSeed | 6.25B |
| J-Pharma | 6.18B |